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Summary
Objectives: To validate an instrument for self-reported hallux valgus (HV).
Methods: The self-report instrument consists of ﬁve line drawings for each foot depicting a sequential increase in HV angle of 15 developed
from a photograph of a normal foot. Participants were asked to select the picture which best represented their left and right feet in turn. Four
hundred and ﬁfty-nine subjects completed the self-report instrument: 100 attending a hospital rheumatology clinic and 359 who participated in
a community questionnaire study. Three hundred and eighty-four completed it on two occasions (1e2 months apart in 71 subjects and 3e6
months apart in 313) and were assessed once by a blinded observer. Twenty-ﬁve subjects were assessed by the blinded observer on two
occasions. Validity of the instrument was assessed by the weighted kappa statistic for subjecteobserver agreement and reliability by the
weighted kappa statistics for subject repeatability and observer repeatability. These analyses were repeated for HV dichotomised as present
or absent.
Results: For the ﬁve-grade HV scale, weighted kappa scores (left and right feet combined) were 0.45 for subjecteobserver agreement, 0.53 at
1e2 months and 0.51 at 3e6 months for subject repeatability, and 0.82 for observer repeatability. For the dichotomised scale (left and right
feet combined), sensitivity was 75% and speciﬁcity was 82%: kappa scores were 0.55 for subjecteobserver agreement, 0.63 at 1e2 months
and 0.61 at 3e6 months for subject repeatability and 0.83 for observer repeatability.
Conclusions: The HV self-report instrument provides a valid and reliable assessment of the presence and severity of HV and appears suitable
for use in epidemiological studies.
ª 2007 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Hallux valgus (HV) is a common deformity characterised by
abnormal angulation, rotation and lateral deviation of the
great toe at the ﬁrst metatarsophalangeal (MTP) joint. Esti-
mates of the community prevalence of HV vary widely,
ranging from 21% to 70%1e5. HV has been reported to be
associated with foot pain1, although other studies have
failed to conﬁrm this association5e7. It also associates
with poor balance8, immobility8 and risk of falling8,9.
An important reason for the inconsistent ﬁndings in stud-
ies of HV is the widely varying deﬁnitions of HV that have
been employed, including ‘‘bunions’’, either self-reported
or conﬁrmed on physical examination, and observer-
assessed HV with no clear description of the deﬁnition
employed. The lack of a validated assessment tool for
self-reported HV is a barrier to large-scale epidemiological
studies of HV. Although a method of grading HV by compar-
ison to a series of photographs has been shown recently to
be a reliable measure when used by research staff and
podiatrists10,11 and to correlate with radiographic HV12, it
has not been validated for self-reported HV.
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Methods
The study was approved by the Nottingham Local
Research Ethics Committees 1 and 2. According to the
requirements of the Research Ethics Committees, verbal
consent to participate was obtained from subjects partici-
pating in the hospital pilot and written consent from those
recruited from the community.
DEVELOPMENT OF THE SELF-REPORT INSTRUMENT
A self-report instrument consisting of line drawings de-
picting varying degrees of HV was developed from a photo-
graph of a normal foot without HV (Fig. 1). Each of the ﬁve
drawings illustrated a sequential increase in HV angle of
15. The drawings were accompanied by instructions for
subjects to compare the line drawings to their own barefeet
without shoes and socks whilst standing and to select
the picture which best represents their left and right feet in
turn.
VALIDATION OF THE SELF-REPORT INSTRUMENT
The instrument was validated in two groups of subjects.
An initial pilot was undertaken in patients attending the08
1009Osteoarthritis and Cartilage Vol. 15, No. 9Fig. 1. Self-report instrument for assessment of HV.rheumatology clinic at Nottingham City Hospital over a
5-day period. All patients attending the clinic, both new
and follow-up, were provided with a study information sheet
and then invited to participate by their clinician. The ﬁrst 100
Table I
Diagnoses of the 459 study participants
Diagnosis n
Gout 167
Osteoarthritis 143
Rheumatoid arthritis 49
Other crystal arthritis 37
Seronegative spondarthropathy 17
Unspeciﬁed inﬂammatory arthritis 12
Tendinopathy 9
Mechanical back pain/ﬁbromyalgia/chronic pain 9
Viral arthritis 5
Connective tissue disease 7
Asymptomatic hyperuricaemia 1
Peripheral oedema 1
Trauma 1
Extrinsic allergic alveolitis 1subjects who agreed to participate were enrolled. The
subjects completed the self-report instrument and a blinded
observer assessed the degree of HV from as close to the
subject’s perspective as possible using the same line draw-
ings. Twenty-ﬁve subjects were seen again 3e6 months
later when both subject and observer assessments were
repeated.
The study was then extended to 359 patients who partic-
ipated in a community-based caseecontrol study of gout
and attacks of self-limiting synovitis. From 4249 question-
naire respondents, 488 subjects who had indicated a history
of gout or attacks of self-limiting synovitis were invited to at-
tend a clinical assessment, 359 of whom agreed to attend.
Table II
Prevalence of grades of HV severity
Observer
assessment
A/F B/G C/H D/I E/J Total
Left foot 107
(23%)
216
(47%)
88
(19%)
28
(6%)
20
(4%)
459
Right foot 112
(24%)
203
(44%)
81
(18%)
36
(8%)
27
(6%)
459
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Weighted kappa scores for five-grade HV scale
Weighted kappa (95% CI)
Left foot Right foot Overall
Subjecteobserver agreement 0.44 (0.38, 0.50) 0.45 (0.40, 0.51) 0.45 (0.41, 0.49)
Subject repeatability (1e2 months) 0.46 (0.30, 0.61) 0.60 (0.45, 0.75) 0.53 (0.42, 0.64)
Subject repeatability (3e6 months) 0.49 (0.42, 0.57) 0.53 (0.45, 0.60) 0.51 (0.46, 0.56)
Observer repeatability 0.79 (0.63, 0.95) 0.84 (0.71, 0.98) 0.82 (0.71, 0.95)These subjects had completed a postal questionnaire which
included the self-report instrument. A face-to-face assess-
ment including blinded observer assessment and repeated
subject self-report was then undertaken in two groups: (1) in
288 respondents seen 3e6 months following the comple-
tion of the questionnaire; and (2) in 71 respondents seen
after 1e2 months after completion of the questionnaire.
All assessments were undertaken by a single observer,
a trainee rheumatologist of 4 years experience (ER).
ANALYSIS
Data from the two sources of recruitment for the study
were combined and cross-tabulated. Validity of the instru-
ment was assessed by the weighted kappa statistic and
its 95% conﬁdence interval (CI) for subjecteobserver agree-
ment (n¼ 459). Reliability was assessed by the weighted
kappa statistics (95% CI) for subject repeatability at 1e2
months (n¼ 71), subject repeatability at 3e6 months
(n¼ 313) and observer repeatability (n¼ 25). Kappa statis-
tics were interpreted as follows: <0.20, poor; 0.21e0.40,
fair; 0.41e0.60, moderate; 0.61e0.80, good; and 0.81e
1.00, very good13. Analysis was performed for left and right
feet combined and then individually.
The HV grade was also dichotomised as present or ab-
sent by classifying the three most severe grades as pres-
ent, speciﬁcally, ‘‘A’’ or ‘‘B’’ (left foot) or ‘‘F’’ or ‘‘G’’ (right
foot) as absent and ‘‘C’’, ‘‘D’’ or ‘‘E’’ (left foot) or ‘‘H’’, ‘‘I’’
or ‘‘J’’ (right foot) as present. Non-weighted kappa and its
95% CI were calculated for subjecteobserver agreement,
subject repeatability at 1e2 months and 3e6 months and
observer repeatability as above. Taking observer assess-
ment as the ‘‘gold standard’’, sensitivity and speciﬁcity of
subject assessment using the dichotomised instrument
were also calculated.
Since it was intended to use the self-report instrument in
a subsequent study to assess the association between HV
and great toe pain, it was important to ensure that HV
severity was not over-reported in subjects with great toe
symptoms. Subjects were classiﬁed as having great toe
symptoms if they reported either a history of acute attacks
of gout or chronic pain at the ﬁrst MTP joint. These data
were only available for community-derived subjects. Pos-
sible over-reporting of HV by subjects with great toe
symptoms was assessed in two ways. Firstly, subject HVassessment on the ﬁve-grade scale was compared to
observer assessment. Subject assessment was classiﬁed
as ‘‘over-reported’’ when it was more severe than observer
assessment, ‘‘correct’’ when it agreed with observer
assessment and ‘‘under-reported’’ when it was less severe
than observer assessment. Odds ratios (ORs) (95% CI)
were calculated between great toe symptoms and reporting
status (i.e., under-reported vs correct subject assessments
and then over-reported vs correct subject assessments).
Secondly, ORs (95% CI) were calculated between great
toe symptoms and subject assessment and then observer
assessment on the dichotomised scale. Indirect comparison
of the ORs was made.
Analyses were performed using SPSS software version
11.0 apart from the weighted kappa statistic which was
calculated at an internet-based statistics application
(http://faculty.vassar.edu/lowry/VassarStats.html).
Results
Four hundred and ﬁfty-nine subjects participated in the
study. Two hundred and thirty-six (51%) were females. Par-
ticipant’s diagnoses are shown in Table I. Prevalence of the
different grades of HV severity is shown in Table II.
Using the ﬁve-grade HV scale, subjecteobserver agree-
ment and subject repeatability at both time points were
moderate (Table III). Agreement was generally similar for
left and right feet apart from subject repeatability at 1e2
months where agreement was better for the right foot than
the left (weighted kappa 0.60 compared to 0.46), although
there was considerable overlap of the 95% CIs. Observer
repeatability was good for the left foot and very good for
the right foot and overall, although numerically the weighted
scores for left and right feet were only 0.05 apart.
Using the dichotomised scale, subjecteobserver agree-
ment was moderate whereas subject repeatability at both
time points was good (Table IV). Observer repeatability
was very good. Again, agreement was similar for left and
right feet apart from subject repeatability at 1e2 months
where agreement for the right foot was better than the left
(unweighted kappa 0.73 vs 0.54), although the 95% CIs
overlapped. Sensitivity was 75% for the left foot, 76% for
the right foot and 75% overall. Speciﬁcity was 82% for the
left foot, 82% for the right foot and 82% overall.Table IV
Kappa scores for dichotomised HV scale
Kappa (95% CI)
Left foot Right foot Overall
Subjecteobserver agreement 0.54 (0.46, 0.62) 0.56 (0.48, 0.64) 0.55 (0.49, 0.61)
Subject repeatability (1e2 months) 0.54 (0.34, 0.75) 0.73 (0.56, 0.89) 0.63 (0.50, 0.77)
Subject repeatability (3e6 months) 0.61 (0.51, 0.71) 0.61 (0.51, 0.70) 0.61 (0.54, 0.68)
Observer repeatability 0.83 (0.60, 1.06) 0.83 (0.61, 1.05) 0.83 (0.67, 0.99)
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OR between subject over-reporting of HV and great toe symptoms
Subject HV reporting OR (95% CI)
Under-reported Correct Over-reported Under-report vs correct Over-report vs correct
Great toe symptoms 50 (15%) 174 (53%) 107 (32%) 1.267 (0.840e1.911) 1.218 (0.870e1.706)
No great toe symptoms 75 (20%) 206 (54%) 104 (27%)Subject assessment of HV severity agreed exactly with
observer assessment in just over half of the observations
made in both subjects with and without great toe symptoms
(Table V). Over-reporting was slightly more frequent in
those with great toe symptoms and under-reporting was
slightly more frequent in those without great toe symptoms
but 95% CIs for the ORs crossed unity.
The presence of great toe symptoms was associated with
subject assessment of HV in the left foot (OR 1.69; 95% CI
1.08, 2.64) and overall (OR 1.52; 95% CI 1.11, 2.07) but not
in the right foot (Table VI). There was no association
between great toe symptoms and observer assessment of
HV. Although this suggests that subjects with great toe
symptoms may over-report HV compared to observer, there
was overlap of 95% CIs on indirect comparison of ORs for
subject and observer assessment.
Discussion
This study describes the validation of the ﬁrst instrument
for subject self-reported HV in a large, mixed population of
hospital and community-derived subjects. Self-reported HV
assessed by this instrument, on either a ﬁve-grade or dicho-
tomised scale, has been shown to be both valid and reliable
and, as such, appears to be suitable for use in a large
community-based epidemiological study. Kappa scores for
subjecteobserver agreement and subject repeatability
were numerically higher using the dichotomised scale com-
pared to the ﬁve-grade scale. However, the difference was
not statistically signiﬁcant (the 95% CI overlapped) suggest-
ing that the validities (subjecteobserver) and reliabilities
(subjectesubject) are similar. The numerical differences
may be due to the greater agreement expected on a dicho-
tomised scale given the smaller number of categories,
which may not have been fully adjusted for by the weighted
kappa statistics.
Most previous studies of HV have relied upon direct clin-
ical assessment which is both costly and time-consuming.
Alternatives include the Manchester scale, a set of four
photographs, which has been validated for use in epidemi-
ological studies but has not been validated for patient self-
report10. Further advantages of the line drawings over the
Manchester scale are a larger number of grades, depiction
of both right and left feet, demonstrated subject repeatability
at 3e6 months (compared to 2 weeks) and validation of
an additional dichotomised deﬁnition of HV. The choice
between the ﬁve-grade and dichotomised grading of HV
allows ﬂexibility according to study design and the precise
research question being asked. The Manchester scale isalso disadvantaged by the depiction of metatarsus primus
varus in addition to HV in the most severe grade and the de-
piction of one left and three right feet in the original report,
although this was corrected for the recent radiographic
validation12.
A number of caveats apply to this study. Some may ques-
tion the biological validity of the line drawings which were
developed from a single photograph of a normal foot with
each grade representing a 15 increase in HV angle rather
than a ‘‘real life’’ model of HV. In contrast, the Manchester
scale consists of four photographs representing ‘‘no defor-
mity’’, ‘‘mild deformity’’, ‘‘moderate deformity’’ and ‘‘severe
deformity’’ chosen from a larger series of photographs
and has been validated against the radiographic hallux ab-
ducto angle12. However, the sequential 15 increase incor-
porated into the line drawings allows a greater degree of
precision of the severity of HV. A second caveat is that
only a single trained observer was used to act as the gold
standard for subject self-assessment, rather than radio-
graphs or the Manchester scale, and has not been validated
against another trained observer. Although the observer’s
assessments were shown to be highly repeatable, no mea-
sure of inter-observer agreement was sought. A further ca-
veat is that the instrument has not been validated in normal
subjects, which is an important consideration as it is in-
tended for use in a community survey. However, although
all of the subjects had musculoskeletal problems, in many
of them the ﬁrst MTP joint was not affected or HV was not
present providing some evidence of wider generalisability.
A fourth caveat concerns the analysis of data combining ob-
servations for left and right feet. Presented data for left and
right feet are not truly independent and for an epidemiolog-
ical study, individuals may be designated HV positive or
negative according to whether either foot is affected by
HV. However, for a validation study such as this one, it is
appropriate to consider observations for left and right feet
combined and separately. In view of the intention to use
this self-report instrument to examine the association of
HV and gout and great toe pain, a ﬁfth caveat concerns
the possibility that subjects with great toe symptoms might
over-report the severity of HV. A small association was
seen between subject assessment of HV and great toe
pain whereas no association was seen between observer
assessment and pain. However, the magnitude of the asso-
ciation between subject assessment was small and when
individual subject observations were classiﬁed as under-
reported, correct or over-reported against the observer as-
sessment, no association between great toe symptoms
and over-reporting of HV severity was found.Table VI
OR between great toe symptoms and HV (grade C/H)
OR (95% CI)
Left Right Overall
Subject assessment 1.692 (1.084, 2.639) 1.360 (0.878, 2.106) 1.518 (1.111, 2.073)
Observer assessment 1.319 (0.815, 2.133) 1.352 (0.807, 2.265) 1.318 (0.928, 1.871)
1012 E. Roddy et al.: Self-report hallux valgus instrumentIn summary, an instrument for patient self-reported HV
consisting of a series of line drawings has been developed.
Both the ﬁve-grade and dichotomised scales of HV appear
to have validity and reliability for use in epidemiological
studies.
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